| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) (NCT04165486) | Ionis Pharmaceuticals, Inc. | 2022-07-21 |
| Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit (NCT04468919) | Oregon Health and Science University | 2022-07-15 |
| Study of ATH434 in Participants with Multiple System Atrophy (NCT05109091) | Alterity Therapeutics | 2022-07-01 |
| Observational Study in Multiple System Atrophy (NCT05453058) | H. Lundbeck A/S | 2022-06-25 |
| CPAP for the Treatment of Supine Hypertension (NCT05489575) | Vanderbilt University Medical Center | 2022-06-23 |
| Community Outreach for Palliative Engagement -- Parkinson Disease (NCT05222386) | University of Rochester | 2022-04-26 |
| Synapse Alterations in MSA Patients (NCT06221644) | Xiangya Hospital of Central South University | 2022-04-01 |
| Biomarkers in Parkinsonian Syndromes (NCT06501469) | Non-profit organization for scientific research in Parkinson's disease and related disorders | 2022-03-23 |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study (NCT06209515) | Kuopio University Hospital | 2022-01-01 |
| Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy (NCT05167721) | Mayo Clinic | 2021-12-15 |
| Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism (NCT03446807) | Loma Linda University | 2021-12-01 |
| An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD) (NCT05638815) | SciNeuro | 2021-11-23 |
| A Study of Lu AF82422 in Participants With Multiple System Atrophy (NCT05104476) | H. Lundbeck A/S | 2021-11-16 |
| Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients (NCT05139342) | Kliniken Beelitz GmbH | 2021-11-15 |
| The Effect of Gluten-free Diet on Parkinsonism (NCT05238545) | General University Hospital, Prague | 2021-10-01 |
| Synaptic Loss in Multiple System Atrophy (NCT05121012) | University of Exeter | 2021-09-01 |
| Optimization of Morphomer-based Alpha-synuclein PET Tracers (NCT05067192) | Skane University Hospital | 2021-07-15 |
| Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy (NCT04965922) | University Hospital, Bordeaux | 2021-07-01 |
| Comprehensive Swallowing Rehabilitation in Patients With MSA (NCT04782284) | Seoul National University Hospital | 2021-05-17 |
| Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms (NCT04782830) | Vanderbilt University Medical Center | 2021-02-05 |
| Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia (NCT05621200) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2021-01-28 |
| Synuclein-One Study (NCT04700722) | CND Life Sciences | 2021-01-04 |
| Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients (NCT04616456) | Brigham and Women's Hospital | 2020-12-30 |
| Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients (NCT04620382) | Vanderbilt University Medical Center | 2020-11-09 |
| Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy (NCT04876326) | Indonesia University | 2020-10-05 |
| Exenatide Once-weekly as a Treatment for Multiple System Atrophy (NCT04431713) | University College, London | 2020-09-16 |
| TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy (NCT04450992) | NYU Langone Health | 2020-06-17 |
| Natural History and Disease Progression Biomarkers of Multiple System Atrophy (NCT04229173) | University Hospital, Toulouse | 2020-05-26 |
| [18F]F-DOPA Imaging in Patients With Autonomic Failure (NCT04246437) | Daniel Claassen | 2020-02-04 |
| A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies (NCT04020198) | Stony Brook University | 2020-01-15 |
| Trial of Parkinson's And Zoledronic Acid (NCT03924414) | California Pacific Medical Center Research Institute | 2019-11-15 |
| Safinamide for Multiple System Atrophy (MSA) (NCT03753763) | Zambon SpA | 2019-10-29 |
| Neurodegenerative Diseases Registry (NCT04472130) | Vincent Mok | 2019-10-09 |
| TMS Treatment in Multiple System Atrophy With Fatigue (NCT04313530) | Xuanwu Hospital, Beijing | 2019-10-01 |
| Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (NCT04184063) | EmeraMed | 2019-09-16 |
| Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms (NCT05748028) | Istituti Clinici Scientifici Maugeri SpA | 2019-06-15 |
| Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy (NCT03901638) | National Taiwan University Hospital | 2019-04-02 |
| Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging (NCT03872102) | University of Texas Southwestern Medical Center | 2019-03-28 |
| Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism (NCT04518059) | University Hospitals Cleveland Medical Center | 2019-03-12 |
| Brain Network Activation in Patients With Movement Disorders (NCT03269201) | Sheba Medical Center | 2019-03-01 |
| Respiratoy Muscle Strength in Patients With Multiple System Atrophy (NCT04287270) | Marmara University | 2019-02-02 |
| Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia (NCT04153110) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2018-12-01 |
| Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy (NCT03593512) | University of Oxford | 2018-09-09 |
| Clinical Laboratory Evaluation of Chronic Autonomic Failure (NCT03648905) | National Institute of Neurological Disorders and Stroke (NINDS) | 2018-09-06 |
| A Futility Trial of Sirolimus in Multiple System Atrophy (NCT03589976) | NYU Langone Health | 2018-09-01 |
| Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101) (NCT04495582) | Corestemchemon, Inc. | 2018-08-28 |
| In-Home Care for Patients With PSP and Related Disorders (NCT03552484) | Rush University Medical Center | 2018-05-30 |
| Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial (NCT03403309) | Yonsei University | 2018-05-02 |
| Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy (NCT03265444) | Corestemchemon, Inc. | 2018-04-13 |
| Automated Abdominal Binder for Orthostatic Hypotension (NCT03482297) | Vanderbilt University Medical Center | 2018-03-01 |
| Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases (NCT04706234) | Kliniken Beelitz GmbH | 2017-09-01 |
| The Swedish BioFINDER 2 Study (NCT03174938) | Skane University Hospital | 2017-05-15 |
| More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease (NCT03076671) | University of Colorado, Denver | 2017-03-01 |
| Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia (NCT03120013) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-02-06 |
| Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension (NCT03042988) | Vanderbilt University Medical Center | 2017-01-30 |
| Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms (NCT04858893) | Ospedale Generale Di Zona Moriggia-Pelascini | 2017-01-01 |
| Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure (NCT02897063) | Vanderbilt University Medical Center | 2016-09-01 |
| Biomarkers in Neural Disorders (NCT02761707) | University of Pennsylvania | 2016-06-01 |
| Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic (NCT02726711) | Vanderbilt University | 2016-04-01 |
| Gait Analysis in Neurological Disease (NCT02994719) | Beth Israel Deaconess Medical Center | 2016-03-01 |
| Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease (NCT02640339) | NYU Langone Health | 2016-02-01 |
| Local Heat Stress in Autonomic Failure Patients With Supine Hypertension (NCT02417415) | Vanderbilt University | 2015-04-01 |
| Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure (NCT02429557) | Vanderbilt University Medical Center | 2015-04-01 |
| Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (NCT02270489) | Affiris AG | 2014-12-11 |
| Water and Sudafed in Autonomic Failure (NCT02149901) | Vanderbilt University | 2014-10-01 |
| Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy (NCT02185677) | University Hospital, Bordeaux | 2014-05-14 |
| Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin. (NCT02064166) | Peter Novak | 2014-02-01 |
| Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA (NCT02071459) | University Hospital, Toulouse | 2014-01-21 |
| Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach (NCT02008721) | Dr. Johannes Levin | 2014-01-01 |
| Biomarkers in Parkinsonian Syndromes (NCT02114242) | University Hospital, Bordeaux | 2013-12-16 |
| Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. (NCT02132052) | University of Colorado, Denver | 2013-11-01 |
| Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes (NCT02445469) | University Hospital, Montpellier | 2012-12-01 |
| Magnetic Resonance Spectroscopy in Autonomic Failure (NCT01607268) | Vanderbilt University | 2012-07-01 |
| Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy (NCT01577992) | University Hospital, Toulouse | 2011-12-01 |
| Natural History Study of Synucleinopathies (NCT01799915) | NYU Langone Health | 2011-06-01 |
| Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure (NCT01292694) | Vanderbilt University | 2011-03-01 |
| Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension (NCT01316666) | Vanderbilt University Medical Center | 2011-03-01 |
| Analysis of the Enteric Nervous System Using Colonic Biopsies (NCT01353183) | Nantes University Hospital | 2010-11-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| The Role of Endothelin in the Supine Hypertension of Autonomic Failure (NCT01119417) | Vanderbilt University | 2010-05-01 |
| Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study (NCT01136213) | University Hospital, Bordeaux | 2010-04-01 |
| Cerebro Spinal Fluid Collection (CSF) (NCT04844060) | University Hospital, Strasbourg, France | 2010-02-01 |
| Nebivolol in the Supine Hypertension of Autonomic Failure (NCT01044693) | Vanderbilt University | 2010-01-01 |
| Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) (NCT00977665) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-12-01 |
| Lithium in Multiple System Atrophy (NCT00997672) | Federico II University | 2009-10-01 |
| Fipamezole in Neurogenic Orthostatic Hypotension (NCT00758849) | Juvantia Pharma Ltd | 2008-09-01 |
| Autonomic Failure Patients for RNA Blood Sampling (NCT00742586) | Vanderbilt University | 2008-07-01 |
| Botulinum A Toxin in Patients With Parkinson's Disease (NCT00822913) | University Of Perugia | 2008-06-01 |
| Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA) (NCT00743561) | University Hospital, Bordeaux | 2008-06-01 |
| Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins (NCT00750867) | University of Massachusetts, Worcester | 2008-06-01 |
| Fluoxetine in Multiple System Atrophy Patients (NCT01146548) | University Hospital, Toulouse | 2008-05-01 |
| Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy (NCT00911365) | Yonsei University | 2008-05-01 |
| Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (NCT00738062) | Chelsea Therapeutics | 2008-01-01 |
| Augmenting Effects of L-DOPS With Carbidopa and Entacapone (NCT00547911) | National Institute of Neurological Disorders and Stroke (NINDS) | 2007-10-01 |
| Research of Biomarkers in Parkinson Disease (NCT00465790) | Institut National de la Santé Et de la Recherche Médicale, France | 2007-10-01 |
| Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease (NCT01155492) | Rush University Medical Center | 2007-09-01 |
| Diagnostic and Prognostic Biomarkers in Parkinson Disease (NCT00653783) | The Parkinson Study Group | 2007-08-01 |
| Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes (NCT00368199) | Maastricht University Medical Center | 2006-09-01 |
| Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy (NCT00103597) | Royal Brisbane and Women's Hospital | 2005-01-01 |
| Cognitive Impairement In Frontotemporal Dementia (NCT03452956) | University of Pennsylvania | 2003-07-01 |